{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:09:15Z","timestamp":1782522555741,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.tmrv.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T02:02:56Z","timestamp":1661652176000},"page":"246-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chop-Chop: The Future of Bacterial Enzymes in Transfusion Medicine"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1923-972X","authenticated-orcid":false,"given":"Erik H.","family":"Klontz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2022.05.003_bib0001","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0002","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1139\/m84-175","article-title":"Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: elastase, an IgG protease","volume":"30","author":"Holder","year":"1984","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0003","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/emboj\/20.12.3046","article-title":"EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG","volume":"20","author":"Collin","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0004","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/emboj\/21.7.1607","article-title":"IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G","volume":"21","author":"Von Pawel-Rammingen","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0005","doi-asserted-by":"crossref","first-page":"17371","DOI":"10.1073\/pnas.0407965101","article-title":"Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG","volume":"101","author":"Wenig","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0006","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/art.22930","article-title":"Blocking of experimental arthritis by cleavage of IgG antibodies in vivo","volume":"56","author":"Nandakumar","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0007","doi-asserted-by":"crossref","first-page":"e1692","DOI":"10.1371\/journal.pone.0001692","article-title":"IdeS: a bacterial proteolytic enzyme with therapeutic potential","volume":"3","author":"Johansson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0008","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/ndt\/gfq115","article-title":"Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes","volume":"25","author":"Yang","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0009","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/mol.113.086470","article-title":"Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase","volume":"83","author":"Tradtrantip","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0010","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/SLA.0000000000002924","article-title":"IdeS (Imlifidase): a novel agent that cleaves human IgG and permits successful kidney transplantation across high-strength donor-specific antibody","volume":"268","author":"Lonze","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0011","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0012","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/TP.0000000000003496","article-title":"Imlifidase desensitization in crossmatch-positive, highly sensitized kidney transplant recipients: results of an international phase 2 trial (highdes)","volume":"105","author":"Jordan","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0013","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1111\/ajt.14733","article-title":"Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients","volume":"18","author":"Lorant","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0014","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1111\/ajt.16754","article-title":"Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients","volume":"21","author":"Kjellman","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0015","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.kint.2019.06.019","article-title":"The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease","volume":"96","author":"Soveri","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0016","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1681\/ASN.2021111460","article-title":"Endopeptidase cleavage of anti-glomerular basement membrane antibodies in vivo in severe kidney disease: an open-label phase 2a study","volume":"33","author":"Uhlin","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0017","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjh.15706","article-title":"Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission","volume":"186","author":"Stubbs","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0018","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/eji.200737581","article-title":"Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis","volume":"37","author":"Nandakumar","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0019","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1073\/pnas.0808248105","article-title":"In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner","volume":"105","author":"Albert","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0020","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1182\/blood-2009-08-239020","article-title":"The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis","volume":"115","author":"Allhorn","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0021","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1073\/pnas.0711271105","article-title":"IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions","volume":"105","author":"Collin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0022","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2009090984","article-title":"IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis","volume":"21","author":"Van Timmeren","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-209","article-title":"IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis","volume":"9","author":"Benkhoucha","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0024","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaut.2012.04.002","article-title":"Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen","volume":"39","author":"Hirose","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ana.23741","article-title":"Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody","volume":"73","author":"Tradtrantip","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0132011","article-title":"Complete removal of extracellular IgG antibodies in a randomized dose-escalation phase I study with the bacterial enzyme IdeS\u2014a novel therapeutic opportunity","volume":"10","author":"Winstedt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0027","unstructured":"Idefirix, INN-imlifidase summary of product characteristics n.d.:1\u201328. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/idefirix-epar-product-information_en.pdf. Accessed 5\/31\/2022."},{"key":"10.1016\/j.tmrv.2022.05.003_bib0028","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.6002\/ect.2021.0234","article-title":"Desensitization regimen consisting of high-dose intravenous immunoglobulin, plasmapheresis, and rituximab (an anti-cd20 antibody), without eculizumab and\/or bortezomib, in 41 highly sensitized kidney transplant recipients","volume":"19","author":"Ishida","year":"2021","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12185-009-0476-1","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"91","author":"Tsai","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0030","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood-2018-04-840090","article-title":"Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura","volume":"132","author":"Jestin","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0031","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0032","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/1744-9987.13718","article-title":"Anti-glomerular basement membrane disease (Goodpasture disease): from pathogenesis to plasma exchange to IdeS","volume":"26","author":"Shin","year":"2022","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0033","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2016.05.015","article-title":"Outcomes of patients with goodpasture syndrome: a nationwide cohort-based study from the French Society of Hemapheresis","volume":"73","author":"Huart","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0034","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0035","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/jth.15433","article-title":"Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme","volume":"19","author":"Kahn","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0036","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJMc2106383","article-title":"PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia","volume":"385","author":"Vayne","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0037","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.kint.2021.09.020","article-title":"Imlifidase as novel treatment strategy in anti-neutrophil cytoplasmic antibody\u2013induced pulmonary-renal syndrome","volume":"100","author":"Enghard","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0038","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/hrt.70.2.101","article-title":"Are streptokinase antibodies clinically important?","volume":"70","author":"Buchalter","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0039","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.4049\/jimmunol.1501929","article-title":"The bacterial enzyme IdeS cleaves the IgG-type of B cell receptor (BCR), abolishes BCR-mediated cell signaling, and inhibits memory B cell activation","volume":"195","author":"J\u00e4rnum","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/BJ20130126","article-title":"EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and \u03b11-acid glycoprotein","volume":"455","author":"Sj\u00f6gren","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0041","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/infdis\/141.4.450","article-title":"Specific proteolysis of human IgA by Streptococcus pneumoniae and Haemophilus influenzae","volume":"141","author":"Mulks","year":"1980","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2022.05.003_bib0042","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/JB.01875-12","article-title":"Identification of a novel host-specific IgM protease in Streptococcus suis","volume":"195","author":"Seele","year":"2013","journal-title":"J Bacteriol"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796322000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796322000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:20:12Z","timestamp":1760138412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796322000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0887796322000360"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2022.05.003","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chop-Chop: The Future of Bacterial Enzymes in Transfusion Medicine","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}